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Among patients with obsessive-compulsive disorder (OCD), 65–85% manifest another
psychiatric disorder concomitantly or at some other time point during their life. OCD
is highly heritable, as are many of its comorbidities. A possible genetic heterogeneity
of OCD in relation to its comorbid conditions, however, has not yet been exhaustively
explored. We used a framework of different approaches to study the genetic relationship
of OCD with three commonly observed comorbidities, namely major depressive disorder
(MDD), attention-deficit hyperactivity disorder (ADHD), and autism spectrum disorder
(ASD). First, using publicly available summary statistics from large-scale genome-wide
association studies, we compared genetic correlation patterns for OCD, MDD, ADHD,
and ASD with 861 somatic and mental health phenotypes. Secondly, we examined how
polygenic risk scores (PRS) of eight traits that showed heterogeneous correlation patterns
with OCD, MDD, ADHD, and ASD partitioned across comorbid subgroups in OCD using
independent unpublished data from the Lundbeck Foundation Initiative for Integrative
Psychiatric Research (iPSYCH). The comorbid subgroups comprised of patients with
only OCD (N = 366), OCD and MDD (N = 1,052), OCD and ADHD (N = 443), OCD
and ASD (N = 388), and OCD with more than 1 comorbidity (N = 429). We found that
PRS of all traits but BMI were significantly associated with OCD across all subgroups
(neuroticism: p = 1.19 × 10−32, bipolar disorder: p = 7.51 × 10−8, anorexia nervosa:
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p= 3.52× 10−20, age at first birth: p= 9.38× 10−5, educational attainment: p= 1.56×
10−4, OCD: p= 1.87× 10−6, insomnia: p= 2.61× 10−5, BMI: p= 0.15). For age at first
birth, educational attainment, and insomnia PRS estimates significantly differed across
comorbid subgroups (p = 2.29 × 10−4, p = 1.63 × 10−4, and p = 0.045, respectively).
Especially for anorexia nervosa, age at first birth, educational attainment, insomnia, and
neuroticism the correlation patterns that emerged from genetic correlation analysis of
OCD, MDD, ADHD, and ASD were mirrored in the PRS associations with the respective
comorbid OCD groups. Dissecting the polygenic architecture, we found both quantitative
and qualitative polygenic heterogeneity across OCD comorbid subgroups.
Keywords: obsessive-compulsive disorder, major depression, attention-deficit/hyperactivity disorder, autism,
comorbidity, polygenic risk score, heterogeneity, genetic correlation
1. INTRODUCTION
Obsessive-Compulsive-Disorder (OCD) is a common, long-
lasting and disabling neuropsychiatric disorder with an estimated
lifetime prevalence of 1–3% (Weissman, 1998; U.S. International
institutes of health (NIH), 2016). It is the fourth most common
psychiatric disorder and has been ranked by the World Health
Organization as being among the most disabling medical
conditions world-wide as it can substantially impair the patient’s
social, occupational and academic functioning (Murray et al.,
1996). OCD is considered a complex disorder with its risk likely
being influenced by hundreds to thousands of genetic variants
scattered across the genome, with small to modest additive
effects (Craig, 2008; Taylor, 2013). Genome-wide association
studies (GWAS) in OCD have found suggestive evidence
for some single nucleotide polymorphisms (SNPs) and genes
that are potentially involved in its pathogenesis (International
Obsessive Compulsive Disorder Foundation Genetics, 2017).
Yet, overall these findings remain rather inconclusive with
no single genetic variant reliably replicating across individual
studies (Sampaio et al., 2013; Bozorgmehr et al., 2017). These
studies did, however, suggest that an increase in sample size
will likely aid the identification of genome-wide significant
loci, following the example of other psychiatric disorders like
major depressive disorder (MDD) (Wray et al., 2018), attention-
deficit hyperactivity-disorder (ADHD) (Demontis et al., 2019),
or autism spectrum disorder (ASD) (Grove et al., 2019). Another
reason for inconclusive findings may be that the majority of
current studies of OCD do not account for or put enough
emphasis on the heterogeneity of the disorder, though genetic
findings may vary as a function of moderator variables (Mataix-
Cols et al., 2005; Kulminski et al., 2016; Mattina and Steiner,
2016). One gene that is implicated in one subgroup of OCD
patients may not be relevant for another, potentially making
it more difficult to find true associations. As 65–85% of OCD
patients manifest another psychiatric disorder concomitantly or
at some other time point during their lifetime (Tükel et al., 2002;
Nestadt et al., 2009; Gillan et al., 2017), often presenting very
different symptoms (Ortiz et al., 2016), it raises the question
whether comorbid patients form distinct (genetic) subgroups.
Nestadt et al. (2009) proposed a sub-classification of OCD
based on comorbidity into three subgroups, with each group
being associated with distinct clinical characteristics, prevalence
rates, age-of-onsets, and sex-distributions. Dissecting OCD into
more homogeneous and accurate sub-phenotypes based on
comorbidity, may therefore lead to the successful identification
of genetic risk variants for OCD (MacRae and Vasan, 2011;
Kulminski et al., 2016).
In recent years, a variety of genetic studies have shown that
OCD shares some genetic background with the neuropsychiatric
disorders it co-occurs with (Cross-Disorder Group of the
Psychiatric Genomics Consortium, 2013; O’Connell et al., 2018).
The genetic correlation of OCD and tourette syndrome (TS)
has been estimated at 0.41 (SE = 0.15) (Davis et al., 2013),
with anorexia nervosa (AN) at 0.49 (SE = 0.13) (Yilmaz et al.,
2020), with MDD at 0.21 (SE = 0.05) (Cross-Disorder Group of
the Psychiatric Genomics Consortium, 2013), with ASD at 0.12
(SE = 0.08) (Cross-Disorder Group of the Psychiatric Genomics
Consortium, 2013), and ranges between -0.17 (SE= 0.07) (Cross-
Disorder Group of the Psychiatric Genomics Consortium, 2013)
and 0.67 (SE = 0.09) (Hirschtritt et al., 2018; Goodman et al.,
2020) for OCD and ADHD.With a quantitative genetic modeling
approach Du Rietz et al. (2020) showed that the phenotypic
association between ADHD and an externalizing factor, also
loading onto OCD, was largely influenced by genetics and it
was demonstrated that both ADHD factors (inattentive and
hyperactive/impulsive symptoms) were genetically related to
OCD (Hirschtritt et al., 2018). PRS derived from ASD genetic
data predicted 0.11% of the phenotypic variance in OCD (Guo
et al., 2017). More recently, evidence for disorder-specific genetic
associations has also been demonstrated. Peyrot and Price (2021)
identified two SNPs distinguishing OCD and ADHD, and one
SNP distinguishing OCD and ASD, using a newly developed
method to quantify the genetic differences between psychiatric
disorders by testing for differences in allele frequencies between
cases of two disorders. It has also been shown that the majority
of genes that have been implicated in OCD, ASD, schizophrenia
(SCZ), and bipolar disorder (BP) are disorder-specific (O’Connell
et al., 2018) and that the phenotypic differences between ADHD
and OCD are reflected in altered DNA methylation at specific
sites, pointing toward heterogeneous regulatory changes in both
disorders (Goodman et al., 2020). As OCD shows such a high and
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specific genetic overlap with its comorbid neurodevelopmental
and psychiatric disorders, while at the same time also presenting
very unique genetic correlates, we explored whether OCD
comorbid subgroups show a heterogeneous genetic architecture
depending on the combination of co-occurring disorders.
In this paper we focused on the potential heterogeneity of
OCD subgroups defined by comorbidity with MDD, ADHD,
and/or ASD, as these disorders form the biggest comorbidity
groups in the iPSYCH OCD sample. While MDD is the most
commonly co-occurring diagnosis with OCD (∼15–39.5%;
Lochner et al., 2014), ADHD occurs in ∼6–34% of OCD cases
(Geller et al., 2004; Anholt et al., 2010) and OCD patients have a
four-fold increased risk of developing ASD (Meier et al., 2015).
Because specific markers associated with OCD have not yet
been identified, we applied a variety of genome-wide analyses,
neither looking for specific associated SNPs nor meta-analysing
the iPSYCH samples with the current PGC OCD GWAS,
as the sample-size increase would have only been marginal.
Instead, in a first step we used publicly available summary
statistics from the PGC to compare the genetic landscape of
OCD patients to patients with either MDD, ADHD, or ASD.
We dissected similarities and differences in correlation patterns
of the four disorders with 861 other phenotypes. In a second
step we used an independent and previously unpublished OCD
dataset from iPSYCH and compared the polygenic architecture
of comorbid samples of patients with an OCD diagnosis
and a further diagnosis of either MDD, ADHD, ASD, or any
combination thereof. We explored differences in polygenic
risk score (PRS) load across the different OCD comorbid
groups using a multivariate (multiple outcomes) multivariable
(multiple covariates) regression, as introduced by Grove et al.
(2019). As training datasets we used eight phenotypes from
a variety of domains (psychiatric, personality/psychological,
anthropomorphic/metabolic, education, and other) that
exhibited a range of differing correlation patterns with OCD,
MDD, ADHD, and ASD. As OCD, MDD, ADHD, and ASD
showed heterogeneous genetic patterns in the analyses in step
one, we hypothesized that (a) the comorbid OCD subgroups in
the iPSYCH sample would show a heterogeneous association
pattern with the PRSes, depending on the training dataset and the
combination of comorbid disorders in the OCD subgroup, and
(b) that this heterogeneity would be in line with the correlation
patterns between OCD, MDD, ADHD, and ASD and the PRS
training phenotypes. We expected that the heterogeneity across
OCD co-morbid subgroups in the PRS analysis would vary
depending on whether the correlations of MDD, ADHD, and
ASD showed the same or opposing directions as OCD with the
traits used as a training dataset in the PRS analyses (see Figure 1




Publicly available European ancestry GWAS summary statistics
of OCD, MDD, ADHD, and ASD were downloaded from the
Psychiatric Genomics Consortium (PGC) website (see here). A
description of sample sizes can be found in Table 1. Details
about the cohorts and data processing have been described in
the corresponding primary publications [OCD: International
Obsessive Compulsive Disorder Foundation Genetics (2017),
MDD: Wray et al. (2018), ADHD: Demontis et al. (2019), ASD:
Grove et al. (2019)].
2.1.2. iPSYCH Comorbid OCD Sample
In the scope of the Danish OCD and Tourette Study (DOTS)
within The Lundbeck Foundation Initiative for Integrative
Psychiatric Research (iPSYCH), Danish nation-wide population-
based case-cohort samples were collected and genotyped. The
study was approved by the Regional Scientific Ethics Committee
in Denmark and the Danish Data Protection Agency. All
analyses of the samples were performed on the secured national
GenomeDK high performance-computing cluster in Denmark
(https://genome.au.dk). See Pedersen et al. (2018) for a detailed
description of the overall cohort, array, genotyping, and quality
control. Here we give a brief summary: The iPSYCH sample
comprised 2,938 individuals with a diagnosis of OCD. All OCD
patients that are included in the iPSYCH sample were either
comorbid with one of the primary disorders in iPSYCH or were
drawn from the population-based pool of controls. For each
iPSYCH sample, DNA was obtained from the Danish Neonatal
Screening Biobank (DNSB) at the Statens Serum Institut
(SSI). Subsequent genotyping was performed in 23 batches on
Illumina’s PsychChip v 1.0 array (Illumina, San Diego, CA,
USA) at the Broad Institute of MIT and Harvard (Cambridge,
MA, USA). Cases were identified amongst all individuals in
iPSYCH (cases and controls) as individuals that met ICD10
diagnostic criteria for OCD (F42). Controls were randomly
selected (for a 4 to 1 matching with cases) from the same cohort,
and excluded individuals with a diagnosis of F42. Genotypes
were processed using the Rapid Imputation and COmputational
PIpeLIne for Genome-Wide Association Studies (ricopili) (Lam
et al., 2020) performing stringent quality control of the data.
Samples with call rates below 98% and individuals with a
mismatch between sex obtained from genotyping and registered
sex in the iPSYCH database were excluded. Related individuals
were removed (randomly one individual per identified pair),
principle component analyses were used to exclude ancestral
outliers and the data was imputed using the 1,000 Genomes
Project phase 3 reference panel (The 1000 Genomes Project
Consortium, 2015). The final dataset included 10,411 controls
and 2,678 cases of which 366 were diagnosed with only OCD
(onlyOCD), 1,052 with OCD and MDD (OCD+MDD), 443 with
OCD and ADHD (OCD+ADHD), 388 with OCD and ASD
(OCD+ASD), and 429 with multiple comorbid disorders (MC)
(see Table 1). Of the cases in the MC subgroup, 127 were
diagnosed with OCD, MDD, and ASD; 140 with OCD, MDD,
and ADHD; 129 with OCD, ASD, and ADHD; and 33 with OCD,
ASD, ADHD, and MDD.
2.2. Statistical Analyses
2.2.1. Gene-Based and Gene-Set Analysis
We performed gene-based- and gene-set association analysis
of the PGC samples of OCD, MDD, ADHD, and ASD using
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FIGURE 1 | Schematic overview of performed analyses. For the first part of the analyses, we used previously published, publicly available GWAS summary statistics
of obsessive-compulsive disorder (OCD), major depressive disorder (MDD), attention-deficit hyperactivity disorder (ADHD), and autism spectrum disorder (ASD) from
the psychiatric genetics consortium (PGC). We used those datasets to compare the polygenic architecture of OCD, MDD, ADHD, and ASD by examining heritability
estimates and genetic correlations (LDSC), their overlap in associated genes and gene-sets (MAGMA/FUMA), and compared each disorders genetic correlation
pattern with 861 other traits and diseases (LDhub). For the second part of the analyses we used an independent and previously unpublished dataset from iPSYCH,
comprising 2,938 individuals with a diagnosis of OCD, of which 366 presented only a diagnosis of OCD, 1,052 a diagnosis of OCD and MDD, 443 a diagnosis of OCD
and ADHD, 388 a diagnosis of OCD and ASD, and 429 a diagnosis of OCD and more than one comorbidity. For these sub-groups we assessed heritability and
genetic correlation estimates (GREML-GCTA) and examined the patterns of association of each comorbid OCD subgroup with eight different polygenic risk scores
(PRS) based on a variety of phenotypes. In a last step we compared the patterns that evolved in the genetic correlation analysis in step one with the patterns of
association that resulted from the PRS analyses of the OCD comorbid subgroups in step two.
the web-based tool Functional Mapping and Annotation of
Genome-Wide Association Studies (FUMA) v1.3.1 (Watanabe
et al., 2017) and Multi-marker Analysis of GenoMic Annotation
(MAGMA) v1.6 (de Leeuw et al., 2015), employing a multiple
regression model while accounting for linkage disequilibrium
(LD) between the markers. For both analyses, the default
MAGMA settings (SNP-wise model for gene analysis and
competitive model for gene-set analysis) were applied. First,
FUMA defines genomic risk loci on the basis of independent
lead SNPs (with r2 < 0.1 between the independent lead SNPs),
merging LD blocks that are physically closer than 250 kb
or overlapping into a single locus. Only SNPs in LD with a
lead SNP and a minimum association p-value of 0.05 were
included for further analysis. Each risk locus is represented
by the top lead SNP with the minimum p-value in the locus.
For MDD, ASD, and ADHD the minimum p-value of included
lead SNPs was set to 5 × 10−8. Because the OCD GWAS
had no SNPs exceeding the genome-wide threshold of 5 ×
10−8 the threshold was arbitrarily lowered to 5 × 10−6. The
minimum allele frequency (MAF) threshold was set to 0.01.
One thousand genomes project phase 3 (The 1000 Genomes
Project Consortium, 2015) was used as a reference panel to
calculate LD across SNPs and genes and the MHC region was
excluded. The gene-based p-values were computed by mapping
SNPs to their corresponding gene(s) on the basis of their position
in the genome. Positional mapping was based on ANNOVAR
annotations and the maximum distance between SNPs and genes
was set to 10 kb. To correct for multiple testing, Bonferroni
correction and false-discovery rate (FDR) was applied for gene-
analysis and gene-set analysis, respectively. For OCD, input
SNPs were mapped to 18,709 protein-coding genes, genome-
wide significance was defined at a Bonferroni corrected threshold
of p = 2.67 × 10−6. FUMA tested curated gene-sets (c2.all)
and gene ontology (GO) terms, using 10,894 gene-sets for
FUMA ≤ version 1.3.0 (ADHD) and 10,655 gene-sets for FUMA
≥ version 1.3.1 (OCD, MDD, ASD). Gene-set p-values were
computed using the gene-based p-values of all genes for each
curated gene-set.
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TABLE 1 | PGC and iPSYCH sample sizes, population prevalences and heritability estimates (h2g).
Phenotype Ncases Ncontrols Ntotal Popprev. h2g (SE) P
PGC
OCD 2,688 7,037 9,725 0.03 0.29 (0.05) –
MDD 59,851 113,154 173,005 0.15 0.09 (0.01) –
ADHD 19,099 34,194 53,293 0.05 0.21 (0.01) –
ASD 18,382 27,969 46,351 0.01 0.11 (0.01) –
iPSYCH
onlyOCD 366 10,411 10,819 0.01 0.29 (0.09) 0.0003
OCD+MDD 1,052 10,411 11,543 0.005 0.08 (0.03) 0.0035
OCD+ADHD 443 10,411 10,901 0.002 0.04 (0.05) 0.2312
OCD+ASD 388 10,411 10,840 0.0003 0.03 (0.04) 0.2289
MC 429 10,411 10,890 0.0001 0.12 (0.03) <0.0001
For PGC samples heritability (h2g ) was estimated using LDSC, for the iPSYCH sub-samples univariate-GREML estimates of SNP-heritability are presented. All heritability estimates are
reported on the liability scale (adjusted for population prevalence). Controls were the same for all iPSYCH subgroups. Abbreviations: Number of cases (Ncases), number of controls
(Ncontrols), total number of individuals (Ntotal), population prevalence (Popprev.) heritability (h2g ), standard error of the heritability estimate (SE), p-value of the heritability estimate (P),
OCD subgroup with more than one comorbidity (MC). Within the MC group, 141 subjects are diagnosed with OCD, MDD, and ASD; 151 subjects are diagnosed with OCD, MDD, and
ADHD, 153 subjects are diagnosed with OCD, ASD, and ADHD; and 34 subjects are diagnosed with OCD, MDD, ASD, and ADHD.
2.2.2. SNP-Heritability Estimates
SNP-heritability (h2g) was estimated using LDSC (Bulik-Sullivan
et al., 2015a,b; Zheng et al., 2017) for the PGC samples and
univariate genetic-relationship restricted maximum likelihood
(GREML) as implemented in Genome-wide Complex Trait
Analysis (GCTA) (Lee et al., 2011; Yang et al., 2011) for the
iPSYCH OCD subgroups, as sample sizes of the subgroups were
too small for LDSC and raw genotype data was available. For
LDSC, freely available precomputed LD scores based on the
European ancestry samples of the 1,000 G phase 3 (The 1000
Genomes Project Consortium, 2015), restricted to HapMap3
SNPs, were used. Before the analysis, standard LDSC filtering was
applied. Poorly imputed SNPs with INFO < 0.9 were removed.
For the conversion of observed-scale- to liability-scale estimates,
previously reported disorder-specific prevalence rates were used
(see Table 1).
For the comorbid iPSYCH samples the univariate GREML
approach of GCTA was used. After removal of ancestry outliers,
counts of each sub-phenotype were the following: controls:
10,411, onlyOCD: 366, OCD+MDD: 1,052, OCD+ADHD: 443,
OCD+ASD: 388, MC: 429. A genetic relatedness matrix (GRM)
was fitted, thereby providing relatedness estimates for all pairwise
combinations of individuals. All indels were removed and the
data was filtered on genotype probability >0.8, missing rate
<0.01 and MAF >0.05. GRM was estimated for each individual
autosome and subsequently merged into a single GRM based
on all autosomes. h2g estimation for each OCD sub-phenotype
was performed including the first four principle components
(PCs) as continuous covariates together with any other PC that
was nominally significantly associated to the phenotype. Waves
were included as categorical indicator covariates. Lacking proper
population prevalence estimates for subgroups, prevalence rates
for comorbid conditions were estimated by multiplying the
prevalence for each comorbid disorder with the OCD prevalence
(3%). The prevalence for the OCD subgroup with more than
one comorbid disorder was estimated to be lower than any of
the other prevalence rates at an arbitrary value of 0.01%, as
the multiplication of more than two prevalence rates would
strongly underestimate the true prevalence. Because at least one
other psychiatric disorder is present in approximately two thirds
of OCD patients (Tükel et al., 2002; Gillan et al., 2017), the
prevalence for only OCD, without any comorbid diagnosis, was
set to 1% (one third of the general OCD prevalence). See Table 1
for a list of all population prevalence estimates.
2.2.3. Genetic Correlation Estimates
Using LDSC (Bulik-Sullivan et al., 2015a,b) we estimated the
genetic correlation (rG) of OCD with MDD, ADHD, and
ASD. We further estimated each disorder’s genetic correlation
with 861 other phenotypes using LDSC as implemented in
LDhub (Zheng et al., 2017) (for 855 traits) and LDSC (for six
additional datasets/traits not contained in the LDhub database).
We corrected for multiple testing by setting the significance
threshold to a Bonferroni-corrected p-value (dividing 0.05 by
the number of valid tests per disorder). We then compared the
correlation patterns that emerged for OCD to those of MDD,
ADHD, and ASD.
Bi-variate GREML as implemented in GCTA was used to
estimate the genetic correlation between the iPSYCH OCD
subgroup samples. The controls were split proportionally in
order to guarantee an independent control group for each
comorbid subgroup in every pairwise comparison.
2.2.4. Multivariate-Multitrait PRS Analyses (PRS)
By applying multivariate (multiple outcomes) multivariable
(multiple covariates) regression (Grove et al., 2019) we examined
the distribution of PRSs based on OCD (International Obsessive
Compulsive Disorder Foundation Genetics, 2017), neuroticism
(Nagel et al., 2018), anorexia nervosa (AN)(Watson et al., 2019),
bipolar disorder (BP) (Stahl et al., 2019), Educational Attainment
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(EA) (Lee et al., 2018), body mass index (BMI) (Yengo et al.,
2018), age at first birth (AFB) (Barban et al., 2016), and insomnia
(Jansen et al., 2019), over the OCD comorbid subgroups. For
the calculation of PRSs, the summary statistics of interest were
clumped by applying standard ricopili parameters. Prior to
clumping overlapping SNPs between the iPSYCH data and the
external summary statistics were extracted and strand ambiguous
A/T and C/G SNPs with a frequency between 0.4 and 0.6 were
removed to avoid potential strand conflicts. PRS were generated
at the default p-value thresholds of 5 × 10−8, 1 × 10−6, 1 ×
10−4, 0.001, 0.01, 0.05, 0.1, 0.2, 0.5, and 1 as a weighted sum of
the risk allele dosages. Prior to analysis scores were normalized.
After the PRS were calculated, the scores were regressed onto
the OCD subgroups to evaluate the genetic overlap between
the phenotypes and the OCD subgroups. Batch effects from
genotyping waves and PCs in the comorbid OCD data were
adjusted for in the multivariate multivariable regression. The
advantage of a multivariate regression is that it can handle a
possible correlation among the PRSes, making it possible to
test a great number of hypotheses across PRSes and subtypes.
The approach is statistically very powerful which enables us
to conduct these analyses even with sample sizes too small to
conduct a GWAS or LDSC analysis.
3. RESULTS
3.1. Comparing the Genetic Architecture of
OCD, MDD, ADHD, and ASD
3.1.1. Gene and Gene-Set Analysis
First, we performed gene-based- and gene-set association analysis
of the PGC samples of OCD, MDD, ADHD, and ASD using
MAGMA/FUMA, thereby looking for potential overlaps in
associated genes and gene-sets between the four disorders. When
looking at 13 genes that showed suggestive association for OCD
(p < 1 × 10−4; strongest association for KIT Proto-Oncogene
Receptor Tyrosine Kinase on chromosome 4, p = 2.46 × 10−7)
there was no evident overlap with significant genes of the
other disorders (see Supplementary Table 1). Furthermore, no
gene-set (p ≤ 9.7 × 10−5) overlapped between OCD, MDD,
ADHD, and ASD (see Supplementary Table 2 for gene-set
results of OCD).
3.1.2. Heritability and Genetic Correlations
Next, we computed SNP heritabilities (h2g) of OCD, MDD,
ADHD, and ASD (see Table 1) and calculated cross-trait genetic
correlations (rG) between each pair of disorders using LDSC
(Bulik-Sullivan et al., 2015a,b). OCD was significantly positively
correlated with MDD (rG = 0.23, SE = 0.07, p = 0.0005)
and nominally significantly negatively correlated with ADHD
(rG =−0.17, SE = 0.07, p= 0.02), while the correlation between
OCD and ASD did not reach significance (rG = 0.12, SE = 0.08,
p= 0.15).
To investigate the extent of genetic overlap between OCD
and an array of other phenotypes, we estimated its genetic
correlations with 861 psychiatric and other medical diseases,
disorders, and traits using bivariate LD score regression (Bulik-
Sullivan et al., 2015a,b; Zheng et al., 2017). The same analysis was
also performed for MDD, ADHD, and ASD as we were interested
in similarities and differences in patterns of correlations between
the four disorders. 777 (for OCD and ADHD), 778 (for
ADHD), and 779 (for MDD) genetic correlations yielded
interpretable results, the remaining estimations resulted in “NA,”
due to small sample size and non-significant heritability. We
therefore set the significance threshold to a Bonferroni-corrected
p-value of 0.05/779 = 6.42 × 10−5. Of the tested diseases
and traits, 45 were significantly correlated with OCD, 249
with MDD, 285 with ADHD, and 52 with ASD (disregarding
a phenotype if has been represented by a different dataset
already). Forty traits overlapped between OCD and MDD, 37
between OCD and ADHD, and 12 between OCD and ASD.
Nine traits were significantly associated with all four disorders,
of which five demonstrated the same direction of effect (see
Supplementary Table 3).
All phenotypes that significantly correlated with
OCD were grouped into five categories: psychiatric,
personality/psychological, anthropomorphic/metabolic,
education, and other (see Figure 2A). Across the four disorders
(OCD, MDD, ADHD, and ASD), differences in their patterns of
correlations emerged. While all four disorders generally showed
positive associations with traits in psychiatric disorders and
personality/psychological traits, ASD and ADHD exhibited fewer
significant and in several cases less strong associations compared
to OCD and MDD. In the category of other, OCD was positively
correlated with fertility parameters (AFB and Age at last life
birth) and movement parameters, and negatively correlated
with all other parameters, while ADHD and MDD generally
showed the opposite pattern of correlation. While OCD and
ASD positively correlated with education traits, ADHD and
MDD negatively correlated with all education parameters (for no
specific qualifications the pattern was reversed). In the category
of anthropomorphic and metabolic traits, OCD significantly
correlated negatively with all reported parameters, while MDD
correlated moderately positively and ADHD strongly positively
with the same phenotypes. In this category, ASD did not
significantly correlate with any of the traits.
We further selected an array of traits across all five domains
(see Figure 2B) to evaluate how PRS based on a broad spectrum
of phenotypes with varying patterns of correlations with OCD,
MDD, ADHD, and ASD, partition across comorbid OCD
subgroups. See section 3.2.2 for details on which traits were
selected for analysis.
3.2. Dissection of the Polygenic
Architecture of Comorbid OCD Subgroups
3.2.1. Heritability and Genetic Correlations Among
the Subgroups
Next, we explored the polygenic heterogeneity across OCD
comorbid subgroups. We examined how h2g partitioned across
the comorbid OCD subgroups and estimated the genetic
correlation among these groups using GCTA (Yang et al.,
2011). Univariate GREML analysis revealed significant h2g for the
onlyOCD, OCD+MDD, andMC subgroups (see Table 1 for all h2g
estimates). Pairwise comparisons of genetic correlations (rG) of
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FIGURE 2 | Genetic correlation patterns of OCD, MDD, ADHD, and ASD with a wide range of other phenotypes. Bivariate LD score regression (LDSC) was used for
the analysis, either as implemented in LDhub or using LDSC. Error bars represent standard errors and asterisks indicate significant associations after
Bonferroni-correction (significance threshold of 6.42 × 10−5, corrected for 779 tests) for multiple testing. (A) Displayed are all traits (N = 45) that significantly
correlated with OCD (yellow), and the respective genetic correlation estimates for MDD (blue), ADHD (pink), and ASD (green), grouped into five different domains
(psychiatric, personality/psychological, other, education, and anthropomorphic/metabolic). (B) Shows the genetic correlation estimates of OCD (yellow), MDD (blue),
ADHD (pink), and ASD (green) with the seven phenotypes (bipolar disorder (BP), anorexia nervosa (AN), Age of first birth (AFB), body-mass index (BMI), educational
attainment (EA), neuroticism, and insomnia) that were selected for subsequent PRS analyses. Here, bar-plots were used to enable easier comparison with the results
from the PRS analyses (see Figure 3). See Supplementary Table 3 for a list of all estimates and references for all used phenotypes. Asterisks indicate significant
associations after Bonferroni-correction (significance threshold of 6.42 × 10−5, corrected for 779 tests) for multiple testing).
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the sub-phenotypes were estimated with bivariate GREML. Each
subgroup demonstrated a high genetic correlation with all other
subgroups (between 0.2 and 1; see Supplementary Table 4 for a
list of the results). Standard errors were generally very high for all
pairwise correlations, making it difficult to interpret the results.
3.2.2. Cross-Trait PRS Analyses
To examine a possible polygenic heterogeneity of OCD, we
further investigated how PRS trained on different phenotypes
(OCD, neuroticism, EA, AN, BP, BMI, AFB, and insomnia)
distribute across the iPSYCH OCD subgroups defined
by a comorbid diagnosis of either MDD, ADHD, and/or
ASD. Traits for the PRS analysis were selected from across
all tested domains (psychiatric, personality/psychological,
anthropomorphic/metabolic, education, and other) and were
chosen in view of their different correlation patterns with OCD,
MDD, ASHD, and ASD. Thereby, we wanted to explore whether
different correlation patterns with OCD, MDD, ADHD, and
ASD would translate into differing patterns in the PRS analysis
across the OCD comorbid subgroups. The traits used as training
datasets in the PRS analysis either showed (a) a significant
correlation with OCD, MDD, ADHD, and ASD in either the
same direction (BMI) or differing directions (EA); or (b) a
significant correlation with OCD and either one (BP) or two
(AFB, BMI, AN) other disorders; or (c) no significant correlation
with OCD but a significant correlation with two other tested
disorders (insomnia). Further, OCD itself was included as a
training dataset for the PRS analysis. With this selection of
phenotypes we aimed to explore whether a heterogeneous
genetic correlation pattern between a phenotype and OCD,
MDD, ADHD, and ASD translates into heterogeneous PRS
loadings in the OCD comorbid subgroups.
The PRS analysis can be read as a linear regression with
the beta value indicating the mean level of PRS relative to
the controls, adjusted for the other variables and covariates
(first four principle components and batches). First, for each
phenotype, it was tested whether the betas of the PRS analyses
were significantly different from zero across all OCD comorbid
subgroups. Neuroticism, BP, AN, AFB, EA, OCD, and insomnia
showed significant associations with the iPSYCH OCD samples
(p = 1.19 × 10−32, p = 7.51 × 10−8, p = 3.52 × 10−20,
p = 9.38 × 10−5, p = 1.56 × 10−4, p = 1.87 × 10−6,
p = 2.61 × 10−5, respectively; see Supplementary Table 5).
Of the eight phenotypes tested (neuroticism, BP, AN, AFB,
EA, OCD, BMI, and insomnia) for association with the
OCD comorbid subgroups, AFB (p = 2.29 × 10−4), EA
(p = 1.63 × 10−4), and insomnia (p = 0.045) showed a
significant heterogeneity across OCD subgroups. BP and AN
were positively associated with all OCD subgroups, while the
other traits showed significant associations with some of the
OCD comorbid subgroups, but not with all (see Figure 3 and
Supplementary Table 6). For AFB the strongest, though non-
significant, positive associations were with the onlyOCD group
(Beta = 0.099, CIl = −0.004, CIu = 0.202, p = 0.059),
followed by the OCD+ASD (Beta = 0.056, CIl = −0.039,
CIu = 0.15, p = 0.247) group. The strongest negative
association was with the OCD+ADHD group (Beta = −0.188,
CIl = −0.288, CIu = −0.088, p = 2.29 × 10−4), followed
by the, though non-significant, MC group (Beta = −0.08,
CIl = −0.176, CIu = 0.015, p = 0.098), and OCD+MDD group
(Beta = −0.067, CIl = −0.13, CIu = −0.004, p = 0.037) (see
Figure 3 and Supplementary Tables 6, 7 for results of all tested
phenotypes). For EA, there was a strong negative association with
OCD+ADHD (Beta = −0.232, CIl = −0.333, CIu = −0.131,
p = 6.36 × 10−6) and a trend for a positive association with
OCD+ASD (Beta= 0.086, CIl=−0.009, CIu= 0.180, p= 0.077),
while the other subgroups demonstrated scores around zero. For
the PRS based on insomnia the strongest positive association was
with the OCD+ADHD (Beta = 0.208, CIl = 0.107, CIu = 0.309,
p = 5.62 × 10−5) group, followed by the MC (Beta = 0.133,
CIl = 0.037, CIu = 0.229, p = 5.62 × 10−3) and the OCD+MDD
group (Beta= 0.084, CIl= 0.021, CIu= 0.148, p= 9.39× 10−3).
4. DISCUSSION
In the present study we first looked at genetic similarities and
differences between OCD and the three psychiatric disorders
MDD, ADHD, and ASD, with a specific emphasis on the genetic
correlation patterns of each of the four disorders with 861
somatic and mental health phenotypes. In a second step we used
genome-wide data of an independent set of OCD patients from
iPSYCH for which we defined five OCD subgroups based on the
patients’ comorbidity withMDD, ADHD and/or ASD (onlyOCD,
OCD+MDD, OCD+ADHD, OCD+ASD, and MC). Using eight
different traits (BP, AN, AFB, BMI, EA, neuroticism, insomnia,
and OCD) as training data sets, we applied PRS analysis
across the comorbid OCD subgroups. Traits were selected
from a variety of domains (psychiatric, personality/psychological,
anthropomorphic/metabolic, education, and other), on the basis
of their differential correlation patterns with OCD, MDD,
ADHD, and ASD. We hypothesized that (a) the comorbid OCD
subgroups show a heterogeneous association pattern with the
PRSes, depending on the training dataset and the combination
of comorbid disorders in the OCD subgroup, and (b) that
the heterogeneous association patterns of the comorbid OCD
subgroups are in accordance with the correlation patterns
between OCD, MDD, ADHD, and ASD and the PRS training
phenotypes that were reported in the first part of the manuscript.
For example, if OCD showed a positive correlation with trait
A and MDD a negative correlation with trait A, we expected
that the onlyOCD group would show a higher association with
the PRS based on trait A than the comorbid subgroup of
OCD+MDD, while we hypothesized that a positive correlation of
both, MDD and OCD, with trait A would translate into either
an increased or similar association of the PRS based on trait
A with the OCD+MDD comorbid subgroup compared to the
onlyOCD group.
The genetic correlation patterns that emerged in the first part
of the analysis are generally in accordance with symptomatic
and clinical observations of OCD, MDD, ADHD, and ASD
patients. As the sample size of a GWAS has an influence on
the standard error and p-value of genetic correlation point
estimates, it was expected that the OCD GWAS showed a
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FIGURE 3 | PRS profile across distinct comorbid OCD subgroups in the iPSYCH sample. The bars show coefficients from multivariate multivariable regression of the
eight normalized PRS over OCD subgroups, adjusting for the first four PCs and for 23 waves, whiskers indicate 95% confidence intervals (CI). Results are shown for
eight different phenotypes: bipolar disorder (BP) (Stahl et al., 2019), anorexia nervosa (AN) (Watson et al., 2019), age at first birth (AFB) (Barban et al., 2016), body
mass index (BMI) (Yengo et al., 2018), educational attainment (EA) (Lee et al., 2018), neuroticism (Nagel et al., 2018), obsessive-compulsive disorder (OCD)
(International Obsessive Compulsive Disorder Foundation Genetics, 2017), and insomnia (Jansen et al., 2019).
lower number of significant genetic correlations with the 861
tested traits, as compared to the larger MDD, ADHD, and
ASD GWASs. We cannot exclude the possibility that with an
increase in sample sizes more genetic correlations will become
significant. However, as we only consider significant genetic
correlations for interpretation, this should not have an influence
on the results discussed here. All four disorders displayed
positive associations with most of the other psychiatric disorders
and with personality/psychological parameters, such as BMI,
worry, and tense feelings. The genetic correlation of OCD with
anthropomorphic and metabolic traits was negative, while MDD
and ADHD showed a positive correlation. This is in line with
the observation that OCD is genetically positively correlated
with AN (The Brainstorm Consortium et al., 2018), as AN
correlates negatively with weight parameters on a symptomatic-
and genetic level (Speranza et al., 2001; Duncan et al., 2017).
OCD and ASD showed a positive correlation with education
parameters and OCD correlated negatively with age at first
birth (there was no significant correlation between ASD and
age at first birth), while the pattern was reversed for ADHD
and MDD. Dalsgaard et al. (2020) recently demonstrated that
males with OCD achieved significantly higher school grades
than individuals without a psychiatric disorder, while people
with other psychiatric disorders (except AN) had significantly
lower grades. It was also shown that higher education and socio-
economic status are associated with higher maternal age at first
birth (Van Roode et al., 2017) and that children of young mothers
were disadvantaged in schooling (Fall et al., 2015).
Because the four disorders showed differential genetic
correlation patterns, we presumed that the polygenic architecture
of comorbid OCD subgroups would vary depending on their
comorbid diagnosis. We first looked at heritability estimates
and genetic correlations between the comorbid OCD subgroups.
The onlyOCD and the MC group demonstrated the highest
heritability estimates, while the OCD+ASD group displayed the
lowest heritability estimates compared to all other subgroups.
As sample sizes in each comorbidity group were quite low, SE
were generally high and not all of the heritability estimates and
none of the genetic correlation estimates between the comorbid
subgroups reached significance.
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In a last step we then applied PRS analysis across the iPSYCH
OCD comorbid subgroups. Rather than selecting traits used as
training datasets on a theoretical or clinical background, they
were selected in view of their different correlation patterns with
OCD, MDD, ADHD, and ASD across a wide range of psychiatric
and somatic phenotypes, as we wanted to explore whether the
different directions of correlations would be mirrored in the
PRS analysis of the OCD comorbid subgroups. For traits for
which OCD, MDD, ADHD, and ASD showed a heterogeneous
genetic correlation pattern (EA, AFB, BMI) we hypothesized that
PRSes based on those traits would also exhibit a heterogeneous
pattern of association with the comorbid OCD subgroups. For
EA and AFB the pattern of PRS loadings that emerged across
the OCD comorbid subgroups closely mirrored the concordance
structure of the genetic correlations between OCD and MDD,
ADHD, and ASD. OCD and ASD correlated positively with Years
of schooling and College or university degree, while it was the
opposite for ADHD and MDD. Accordingly, in the PRS analysis
the OCD+ADHD group had the highest negative loading for
EA, while the EA PRS estimate was positive in the OCD+ASD
group. Similarities between the correlation analysis and PRS
analysis could also be shown for AFB. OCD correlated positively,
MDD and ADHD negatively with AFB. ASD did not show a
significant correlation. Similarly, in the PRS analysis, AFB was
positively associated with disease status in the onlyOCD group
and to a lower degree also in the OCD+ASD group, while it was
negatively associated with the OCD+MDD, OCD+ADHD, and
MC group. The PRS loadings for BMI was the most negative
for the onlyOCD group, but also showed a negative association
with OCD+ASD and MC, while, somewhat surprisingly, the
other OCD subgroups were not significantly associated with
the BMI PRS. One possible explanation for this pattern may
be that the negative correlation between OCD and BMI and
the positive correlations between ADHD and BMI, as well
as between MDD and BMI translate into a null-finding in
the PRS finding for BMI because the opposing correlations
may evoke counteracting effects in the comorbid subgroups.
As neuroticism showed a fairly homogeneous correlation with
OCD, MDD, ADHD, and ASD, we expected no polygenic
heterogeneity across comorbid OCD subgroups. Similarly, for
AN and BP, which correlated significantly positively with OCD
and MDD, and positively but non-significantly with ASD and
ADHD, we expected a rather homogeneous pattern of association
with PRSs across the subgroups, with stronger associations
for onlyOCD and OCD+MDD. This was indeed the case, as
PRSes of neuroticism, and BP were associated with OCD
across all comorbid subgroups with no significant differences
in estimates between the OCD comorbid subgroups. For AN,
the pattern of correlations was mirrored closely in the PRS
analysis—onlyOCD and OCD+MDD demonstrated the highest
PRS estimates, followed by OCD+ASD and OCD+ADHD, with a
significant difference between the highest estimate for onlyOCD
and the lowest estimate for OCD+ADHD. Because we were also
interested how PRS estimates change for traits which showed
no correlation with OCD but with some of the other three
disorders, we also included insomnia in the PRS analysis. While
the insomnia PRS was not significantly associated with the
onlyOCD subgroup, it showed significant associations with the
OCD+MDD, OCD+ADHD, and MC subgroups, indicating that
a comorbid diagnosis might change the association of OCD
and insomnia.
To conclude, the different PRS estimates across OCD subsets
provide the first evidence for a heterogeneous and qualitatively
different genetic architecture of OCD subgroups defined by a
comorbid diagnosis of MDD, ADHD, and/or ASD. Traits that
show a heterogeneous genetic correlation pattern with OCD,
MDD, ADHD, and ASD generally also exhibit a heterogeneous
pattern of estimations in PRS analysis across OCD comorbid
subgroups. This was especially shown for AFB, and EA. While
being unique in its approach, results of the present study are in
accordance with previous research by Hirschtritt et al. (2018)
who examined OCD- and ADHD-symptom dimensions in TS
cases and identified unique OCD symptom subgroups that
were differentially associated with other comorbid psychiatric
disorders. Both, OCD symptom subgroups and comorbid
subgroups, may be markers of distinct underlying patterns of
psychopathology and genetic architecture.
Because heterogeneous genetic architectures could potentially
point toward heterogeneous disease mechanisms, the context in
which OCD occurs may have implications for diagnostic criteria
and treatment that might not have been considered sufficiently
in past and present research and clinical practice. Pallanti et al.
(2011), for example, showed that OCD in the presence of
comorbid conditions is often associated with non-response to
treatment, indicating differential clinical characteristics. Also,
for the success of GWAS analyses, it may be beneficial to
focus on (sub)phenotype definitions rather than solely relying
on increasing sample size. As MacRae and Vasan (2011) and
Kulminski et al. (2016) have discussed, increasing the size
of many human disease cohorts is likely only to upscale the
heterogeneity in parallel. Especially for cross-disorder GWAS
analyses, which have gained a lot of attention recently (Cross-
Disorder Group of the Psychiatric Genomics Consortium,
2013; Grotzinger et al., 2019; Lee et al., 2019; Abdellaoui
et al., 2020), it may be crucial to account for comorbidities
to avoid confounding of genetic similarities and differences
between psychiatric disorders. One limitation of this study is
the right censoring of comorbidities. While ADHD and ASD
are neurodevelopmental disorders with mostly a childhood onset
(and some persistency into adulthood), MDD usually occurs
with an onset in late adolescence and adulthood. Therefore,
the possibility that an individual develops a comorbidity, or
another comorbidity on top of an already existing one, cannot
be ruled out and may be higher for disorders with a later age
of onset. Inherently, iPSYCH is a longitudinal study. As with
other studies, however, it may be the case that some study
participants (e.g., those originally ascertained for their ADHD
and/or ASD diagnosis) were included at a time point at which
the follow-up time was not sufficient to capture a later diagnosis
of one of the comorbidities under study (e.g., MDD). While
right censoring may dampen some of the observed effects, it
is unlikely to alter the overall observations of this study and
its main finding of a heterogeneous genetic architecture of
comorbid subgroups.
Frontiers in Genetics | www.frontiersin.org 10 August 2021 | Volume 12 | Article 711624
Strom et al. Polygenic Heterogeneity Across OCD Subgroups
The present study should be viewed as a pilot study and
exploratory in nature. In the future, it would be of interest
to conduct similar analyses with a broader range of correlated
phenotypes and to include other related and comorbid disorders,
such as schizophrenia, BP, AN, Tourette’s syndrome and anxiety
disorders. It has also been suggested that the onset of OCD
(early vs. late) (Hemmings et al., 2004; Walitza et al., 2010;
Taylor, 2011), sex (male vs. female) (Khramtsova et al., 2019),
or different symptom dimensions of OCD (Hasler et al., 2005)
present differing underlying genetic architectures.
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